# Haikou Gangyin

> Haikou Gangyin is a VC fund in Haikou backing Biopharma, Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Haikou, China
- Total investments: 1
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Haikou Gangyin is a VC fund in Haikou focused on Biopharma and Health Care. Haikou Gangyin operates as a regional equity investment firm specializing in venture capital allocation and targeted corporate financing. The firm focuses on deploying capital into high-growth sectors, including healthcare and biotechnology. Its core value proposition centers on delivering institutional backing and strategic resource alignment toemerging enterprises. Through these private equity structures, the entity assists portfolio companies in scaling infrastructure and expanding operational capacity.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MingCeler | MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology. It provides high-end, fast, and excellent model biological technology services and resources for pharmaceutical companies, vaccine companies, universities, research institutes, hospitals, and other life and health-relatedresearch teams. |  | Series A | Jul 13, 2026 |  |

1 of 1 investments shown.

## Co-investors
- Synergetic Innovation Fund Management — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Haikou Gangyin invest in?

Haikou Gangyin invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Haikou Gangyin last invest?

The most recent investment recorded for Haikou Gangyin closed in Jul 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co